Mark Elliott Boulding - 10 Jan 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
EXEC. VP AND CLO
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
10 Jan 2023
Net transactions value
-$47,288
Form type
4
Filing time
12 Jan 2023, 15:38:43 UTC
Previous filing
11 Jan 2023
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $25,330 -590 -0.76% $42.93 76,685 10 Jan 2023 Direct F1
transaction PTCT Common Stock Sale $21,958 -495 -0.65% $44.36 76,190 11 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.